Company Filing History:
3 out of 46 
2 out of 80 
Years Active: 2017-2024
Title: Eddie Costa: Innovator in Nitric Oxide Administration
Introduction
Eddie Costa is a notable inventor based in San Diego, California. He has made significant contributions to the field of medical technology, particularly in the administration and monitoring of nitric oxide in ex vivo fluids. With a total of five patents to his name, Costa's work has the potential to enhance organ preservation and improve patient outcomes in medical procedures.
Latest Patents
One of Eddie Costa's latest patents focuses on the administration and monitoring of nitric oxide in ex vivo fluids. This patent describes systems and methods for effectively monitoring the administration of nitric oxide (NO) to various ex vivo fluids. Examples of these fluids include blood in extracorporeal membrane oxygenation (ECMO) circuits and perfusion fluids used for preserving ex vivo organs prior to transplantation. The systems and methods outlined in this patent provide a framework for administering nitric oxide to the fluid, monitoring nitric oxide or a nitric oxide marker in the fluid, and adjusting the nitric oxide administration as necessary.
Career Highlights
Throughout his career, Eddie Costa has worked with prominent companies in the pharmaceutical and medical device industries. Notably, he has been associated with Mallinckrodt Pharmaceuticals and Mallinckrodt Hospital Products. His experience in these organizations has allowed him to develop innovative solutions that address critical medical challenges.
Collaborations
Eddie Costa has collaborated with several professionals in his field, including Jim Potenziano and Douglas R. Hansell. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Eddie Costa is a distinguished inventor whose work in nitric oxide administration has the potential to revolutionize medical practices related to organ preservation and patient care. His contributions to the field are significant, and his patents reflect a commitment to innovation in healthcare technology.